X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Indian equity markets trade in green 
(Wed, 5 Jun 01:30 pm) 
 
Indian equity markets have recovered some losses and are trading above the dotted line during the post noon trading session. Most noticeable upward movement is being noticed in the stocks from oil & gas and realty sector, however stocks from the IT and FMCG sectors are witnessing maximum selling pressure.

BSE-Sensex is up by 36 points and NSE-Nifty is trading down up by 8 points. While BSE Mid Cap is trading up by 0.12%, BSE Small Cap index is trading up by 0.22%. The rupee is trading at 56.50 to the US dollar.

FMCG stocks are trading mixed with Jyothy Consumer and Emami being the major gainers and P&G Hygiene and Godrej Consumer Products (GCPL) being the biggest losers. As per a leading financial daily, GCPL is contemplating entering the salon business and is reportedly in talks with Mumbai-based hair dressing and salon chain b:blunt. However, the company wants to enter the salon business more in terms of the salon brand rather than a service offering. The company already has a niche hair styling global brand - Salon Selectives that it has added to its portfolio through the acquisition of UK based Keyline Brands in 2005. This brand competes with other salon brands such as L'Oreal and Schwarzkopf and has a line of hair care products ranging from shampoos, hair conditioners, mousses, sprays, gels and oils. The company is exploring the possibility of introducing the Salon Selective brand that recently became a part of the Keyline Brands portfolio.

Domestic pharma stocks are trading mixed with, Elder Pharma and Sun Pharma leading among gainers while Cadila Healthcare and JB Chemicals are the major losers. Cadila has recently announced that the company has achieved a significant milestone for Lipaglyn drug in its research and development pipeline. The said drug will be first NCE (new chemical entity) to reach Indian markets. This is the world's first drug for treating diabetic dyslipidemia. The drug combines lipid and glucose lowering effects in one single molecule. The drug has been approved for launch in India by DCGI (Drug Controller and General of India). Diabetic Dyslipidemia is a condition where a person is diabetic and has elevated levels of cholesterol. India has a population of approximately 65 m diabetics and 77 m pre-diabetics. Above 85% of patients suffer dylipidemia abnormalities. Cadila was trading down by 4%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Indian equity markets trade in green". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Jul 25, 2017 (Close)

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS